General Information of DME (ID: DED2FW3)

DME Name Aldo-keto reductase 1A1 (AKR1A1) DME Info
Gene Name AKR1A1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Approved Drug(s)
Investigative Drug(s)
3 Approved Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [1]
Ethanol DMDRQZU Chronic pain MG30 Approved [2]
NADH DM5NM6E Parkinson disease 8A00.0 Approved [3]
------------------------------------------------------------------------------------
4 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
2,3-dihydroxypropanal DMOWNB4 Discovery agent N.A. Investigative [4]
BRN-0471734 DMZMWVX N. A. N. A. Investigative [4]
D-glucuronate DM1YBTC N. A. N. A. Investigative [4]
Nitrobenzaldehyde DM4UHB5 N. A. N. A. Investigative [4]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab Dispos. 2008 Oct;36(10):2113-20.
2 Functional assessment of human alcohol dehydrogenase family in ethanol metabolism: significance of first-pass metabolism. Alcohol Clin Exp Res. 2006 Jul;30(7):1132-42.
3 Conformational changes and catalysis by alcohol dehydrogenase. Arch Biochem Biophys. 2010 Jan 1;493(1):3-12.
4 The C-terminal loop of aldehyde reductase determines the substrate and inhibitor specificity. Biochemistry. 1996 Nov 12;35(45):14276-80.